These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

363 related articles for article (PubMed ID: 29916024)

  • 1. Lost in Translation: Evidence for Protein Synthesis Deficits in ALS/FTD and Related Neurodegenerative Diseases.
    Lehmkuhl EM; Zarnescu DC
    Adv Neurobiol; 2018; 20():283-301. PubMed ID: 29916024
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pathogenic determinants and mechanisms of ALS/FTD linked to hexanucleotide repeat expansions in the C9orf72 gene.
    Wen X; Westergard T; Pasinelli P; Trotti D
    Neurosci Lett; 2017 Jan; 636():16-26. PubMed ID: 27619540
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RNA binding proteins and the pathological cascade in ALS/FTD neurodegeneration.
    Ito D; Hatano M; Suzuki N
    Sci Transl Med; 2017 Nov; 9(415):. PubMed ID: 29118263
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Post-translational modifications on RNA-binding proteins: accelerators, brakes, or passengers in neurodegeneration?
    Sternburg EL; Gruijs da Silva LA; Dormann D
    Trends Biochem Sci; 2022 Jan; 47(1):6-22. PubMed ID: 34366183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALS and FTD: Where RNA metabolism meets protein quality control.
    Mandrioli J; Mediani L; Alberti S; Carra S
    Semin Cell Dev Biol; 2020 Mar; 99():183-192. PubMed ID: 31254610
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TDP-43-mediated neurodegeneration: towards a loss-of-function hypothesis?
    Vanden Broeck L; Callaerts P; Dermaut B
    Trends Mol Med; 2014 Feb; 20(2):66-71. PubMed ID: 24355761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insights into the pathogenic mechanisms of Chromosome 9 open reading frame 72 (C9orf72) repeat expansions.
    Todd TW; Petrucelli L
    J Neurochem; 2016 Aug; 138 Suppl 1():145-62. PubMed ID: 27016280
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Induction of autophagy mitigates TDP-43 pathology and translational repression of neurofilament mRNAs in mouse models of ALS/FTD.
    Kumar S; Phaneuf D; Cordeau P; Boutej H; Kriz J; Julien JP
    Mol Neurodegener; 2021 Jan; 16(1):1. PubMed ID: 33413517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TDP-43 and FUS in amyotrophic lateral sclerosis and frontotemporal dementia.
    Mackenzie IR; Rademakers R; Neumann M
    Lancet Neurol; 2010 Oct; 9(10):995-1007. PubMed ID: 20864052
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-to-Cell Transmission of Dipeptide Repeat Proteins Linked to C9orf72-ALS/FTD.
    Westergard T; Jensen BK; Wen X; Cai J; Kropf E; Iacovitti L; Pasinelli P; Trotti D
    Cell Rep; 2016 Oct; 17(3):645-652. PubMed ID: 27732842
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Common Molecular Pathways in Amyotrophic Lateral Sclerosis and Frontotemporal Dementia.
    Weishaupt JH; Hyman T; Dikic I
    Trends Mol Med; 2016 Sep; 22(9):769-783. PubMed ID: 27498188
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nucleocytoplasmic transport in C9orf72-mediated ALS/FTD.
    Zhang K; Grima JC; Rothstein JD; Lloyd TE
    Nucleus; 2016 Apr; 7(2):132-7. PubMed ID: 27116041
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular basis of ALS and FTD: implications for translational studies.
    Liščić RM
    Arh Hig Rada Toksikol; 2015 Dec; 66(4):285-90. PubMed ID: 26751860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Delineating the relationship between amyotrophic lateral sclerosis and frontotemporal dementia: Sequence and structure-based predictions.
    Kumar V; Islam A; Hassan MI; Ahmad F
    Biochim Biophys Acta; 2016 Sep; 1862(9):1742-54. PubMed ID: 27318084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Microglia and C9orf72 in neuroinflammation and ALS and frontotemporal dementia.
    Lall D; Baloh RH
    J Clin Invest; 2017 Sep; 127(9):3250-3258. PubMed ID: 28737506
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Vulnerability of microRNA biogenesis in FTD-ALS.
    Eitan C; Hornstein E
    Brain Res; 2016 Sep; 1647():105-111. PubMed ID: 26778173
    [TBL] [Abstract][Full Text] [Related]  

  • 17. UBQLN2/P62 cellular recycling pathways in amyotrophic lateral sclerosis and frontotemporal dementia.
    Fecto F; Siddique T
    Muscle Nerve; 2012 Feb; 45(2):157-62. PubMed ID: 22246868
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ALS and FTD: an epigenetic perspective.
    Belzil VV; Katzman RB; Petrucelli L
    Acta Neuropathol; 2016 Oct; 132(4):487-502. PubMed ID: 27282474
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Impaired protein degradation in FTLD and related disorders.
    Götzl JK; Lang CM; Haass C; Capell A
    Ageing Res Rev; 2016 Dec; 32():122-139. PubMed ID: 27166223
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Tale of two diseases: amyotrophic lateral sclerosis and frontotemporal dementia.
    Verma A
    Neurol India; 2014; 62(4):347-51. PubMed ID: 25237937
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.